Nuveen LLC Takes $11.79 Million Position in Teladoc Health, Inc. $TDOC

Key Points

• Nuveen LLC has acquired approximately 1.48 million shares of Teladoc Health, Inc. during the first quarter, valuing the investment at about $11.79 million, which represents a 0.84% stake in the company.
• Several large investors, including Cambridge Investment Research and Golden State Wealth Management, have significantly increased their holdings in Teladoc Health by over 60% in the first quarter.
• Analyst reports reflect a cautious outlook for Teladoc Health, with target price reductions from various financial institutions, leading to a consensus rating of "Hold" and an average price target of $9.75.

Nuveen LLC acquired a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquired 1,481,018 shares of the health services provider's stock, valued at approximately $11,789,000. Nuveen LLC owned 0.84% of Teladoc Health at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of TDOC. Golden State Wealth Management LLC increased its holdings in shares of Teladoc Health by 102.6% during the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after purchasing an additional 1,690 shares in the last quarter. National Bank of Canada FI boosted its stake in Teladoc Health by 79.4% during the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock worth $28,000 after purchasing an additional 1,581 shares during the last quarter. Sterling Capital Management LLC boosted its position in shares of Teladoc Health by 776.7% during the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after acquiring an additional 4,101 shares during the last quarter. Brucke Financial Inc. acquired a new position in shares of Teladoc Health during the 4th quarter valued at about $92,000. Finally, Westside Investment Management Inc. boosted its position in shares of Teladoc Health by 16.8% during the 1st quarter. Westside Investment Management Inc. now owns 10,750 shares of the health services provider's stock valued at $86,000 after acquiring an additional 1,550 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Adam C. Vandervoort sold 5,808 shares of Teladoc Health stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $39,842.88. Following the transaction, the insider directly owned 69,773 shares of the company's stock, valued at $478,642.78. The trade was a 7.68% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Fernando M. Rodrigues sold 4,174 shares of the business's stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total value of $28,842.34. The disclosure for this sale can be found here. Insiders have sold 18,656 shares of company stock valued at $128,189 in the last three months. Corporate insiders own 0.58% of the company's stock.

Teladoc Health Price Performance

Teladoc Health stock traded down $0.01 during midday trading on Monday, reaching $7.67. 4,618,388 shares of the company were exchanged, compared to its average volume of 7,180,080. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. The company has a market capitalization of $1.36 billion, a price-to-earnings ratio of -6.45 and a beta of 1.76. The firm's 50-day simple moving average is $7.74 and its 200-day simple moving average is $8.14. Teladoc Health, Inc. has a 1 year low of $6.35 and a 1 year high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.08. The company had revenue of $631.90 million during the quarter, compared to analysts' expectations of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The firm's revenue was down 1.6% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. On average, analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Canaccord Genuity Group decreased their target price on shares of Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a research note on Thursday, May 1st. Bank of America lowered their price target on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a report on Wednesday, May 28th. Evercore ISI increased their price objective on Teladoc Health from $7.00 to $8.00 and gave the company an "in-line" rating in a report on Wednesday, July 9th. Finally, The Goldman Sachs Group decreased their price objective on Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Six research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $9.75.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.